Procysbi: Nephropathic Cystinosis Drug Approved By FDA
Raptor's shares rose as much as 15.6 percent on Tuesday. WASHINGTON, April 30 (Reuters) - The U.S. Food and Drug Administration
procysbi nephropathic cystinosis drug approve fda raptor share rise percent t USA ay washington april reuters  USA  food drug administration